A multicenter randomized phase III study comparing paclitaxel-cisplatin-etoposide (TEP) versus cisplatin-etoposide (EP) as front-line treatment in patients with small cell lung cancer (SCLC)
- 30 September 2000
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 29 (1) , 29
- https://doi.org/10.1016/s0169-5002(00)80091-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: